Akebia Therapeutics Expects To Resubmit NDA For Vadadustat NDA In Q3

Akebia Therapeutics Resubmits NDA For Vadadustat To FDA

Biopharmaceutical company Akebia Therapeutics, Inc. (AKBA) announced Thursday it has resubmitted its New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for vadadustat for the treatment of anemia due to chronic kidney disease (CKD) in adult patients on dialysis.

RTTNews | 726 วันที่ผ่านมา

Singapore Bourse May Hand Back Tuesday's Gains

The Singapore stock market on Tuesday finally halted the seven-day losing streak in which it had slumped more than 55 points or 1.3 percent. The Straits Times Index now sits just above the 4,300-point plateau although it may head south again on Wednesday.

RTTNews | 6 นาทีที่ผ่านมา

Rally May Stall For Malaysia Stock Market

The Malaysia stock market has ticked higher in two straight sessions, collecting more than 5 points or 0.3 percent along the way. The Kuala Lumpur Composite Index now sits just above the 1,600-point plateau although it may run out of steam on Wednesday.

RTTNews | 36 นาทีที่ผ่านมา

Renewed Selling Pressure Likely For Japan Stock Market

Ahead of Tuesday's holiday for the Autumnal Equinox, the Japanese stock market had alternated between positive and negative finishes through the previous four trading days, since the end of the four-day winning streak in which it had surged more than 1,430 points or 3.2 percent. The Nikkei 225 now sits just beneath the 45,500-point plateau and it's looking at a soft start on Wednesday.

RTTNews | 51 นาทีที่ผ่านมา

KOSPI Due For Profit Taking On Wednesday

The South Korea stock market has finished higher in back-to-back sessions, advancing more than 40 points or 1.1 percent along the way. Now at another fresh record closing high, the KOSPI sits just above the 3,485-point plateau although investors are likely to lock in gains on Wednesday.

RTTNews | 1 ชม. 6 นาทีที่ผ่านมา